Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,596 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Reduced-intensity conditioning by fludarabine/busulfan without additional irradiation or T-cell depletion leads to low non-relapse mortality in unrelated bone marrow transplantation.
Nakane T, Nakamae H, Koh H, Nakamae M, Hayashi Y, Nishimoto M, Yoshimura T, Inoue E, Inoue A, Aimoto R, Aimoto M, Terada Y, Koh KR, Yamane T, Hino M. Nakane T, et al. Among authors: inoue e, inoue a. Int J Hematol. 2011 Apr;93(4):509-516. doi: 10.1007/s12185-011-0805-z. Epub 2011 Mar 12. Int J Hematol. 2011. PMID: 21394567
Factors that contribute to long-term survival in patients with leukemia not in remission at allogeneic hematopoietic cell transplantation.
Koh H, Nakamae H, Hagihara K, Nakane T, Manabe M, Hayashi Y, Nishimoto M, Umemoto Y, Nakamae M, Hirose A, Inoue E, Inoue A, Yoshida M, Bingo M, Okamura H, Aimoto R, Aimoto M, Terada Y, Koh KR, Yamane T, Ohsawa M, Hino M. Koh H, et al. Among authors: inoue e, inoue a. J Exp Clin Cancer Res. 2011 Apr 10;30(1):36. doi: 10.1186/1756-9966-30-36. J Exp Clin Cancer Res. 2011. PMID: 21477348 Free PMC article.
[A modified myeloablative conditioning regimen for allogeneic hematopoietic stem cell transplantation, consisting of intravenous busulfan, cyclophosphamide and total lymphoid irradiation, in advanced leukemia].
Nakamae H, Terada Y, Nakane T, Koh H, Nakamae M, Aimoto R, Hirose A, Hayashi Y, Nishimoto M, Inoue E, Yoshimura T, Inoue A, Koh KR, Yamane T, Hino M. Nakamae H, et al. Among authors: inoue e, inoue a. Gan To Kagaku Ryoho. 2010 Sep;37(9):1691-5. Gan To Kagaku Ryoho. 2010. PMID: 20841930 Japanese.
A rare t(4;12)(q12;p13) in an adolescent patient with acute myeloid leukemia.
Manabe M, Nakamura K, Inaba A, Fujitani Y, Kosaka S, Yamamura R, Inoue A, Hino M, Senzaki H, Ohta K. Manabe M, et al. Among authors: inoue a. Cancer Genet Cytogenet. 2010 Jul 1;200(1):70-2. doi: 10.1016/j.cancergencyto.2010.03.012. Cancer Genet Cytogenet. 2010. PMID: 20513538 No abstract available.
Association Between the Rewarming Duration and Neurological Outcomes after Extracorporeal Cardiopulmonary Resuscitation Followed by Targeted Temperature Management for Out-of-Hospital Cardiac Arrests: A Secondary Analysis of the SAVE-J II Study.
Miyamoto S, Hifumi T, Komori A, Iriyama H, Abe T, Inoue A, Sakamoto T, Kuroda Y, Otani N; SAVE-J II study group. Miyamoto S, et al. Among authors: inoue a. Ther Hypothermia Temp Manag. 2024 Sep 23. doi: 10.1089/ther.2024.0036. Online ahead of print. Ther Hypothermia Temp Manag. 2024. PMID: 39311769
Reliable intraoperative diagnostic methods for PCNSL: utility of combining intraoperative immunohistochemistry, cytology, and flow cytometry in achieving optimal treatment.
Inoue A, Miyazaki Y, Watanabe H, Nishikawa M, Kusakabe K, Ohnishi T, Taniwaki M, Honda T, Kondo T, Kinnami S, Katayama E, Shigekawa S, Kurata M, Kitazawa R, Kunieda T. Inoue A, et al. Acta Neurol Belg. 2024 Sep 21. doi: 10.1007/s13760-024-02637-3. Online ahead of print. Acta Neurol Belg. 2024. PMID: 39306596
2,596 results